GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...
Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...
In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...
He’s openly criticized the FDA and has called for an end to the regulatory oversight of many health products, including ...
We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...
Shanghai Daily on MSN1d
Expo promotes family-friendly products and servicesA family-friendly concept is highlighted at the China International Import Expo, ranging from disease care, driving safety and baby's products.Medical professionals, sociologists, health officials, en ...
and GSK, were among several accused in lawsuits of deceiving consumers about cold medicines containing the ingredient. The ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. Read More on GB:GSK: GSK NewsMORE Related Stocks Indices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback